DuPont de Nemours : Exercises Option to Acquire OxyMem
December 18, 2019 at 11:06 am EST
Share
WILMINGTON, Del., Dec. 18, 2019 - DuPont (NYSE: DD) today announced it has exercised its option to acquire full ownership of OxyMem Limited, a company that develops and produces Membrane Aerated Biofilm Reactor (MABR) technology for the treatment and purification of municipal and industrial wastewater. OxyMem has more than 60 employees and one production site located in Athlone, Ireland. The transaction will close before Dec. 31, 2019.
Attachments
Original document
Permalink
Disclaimer
DuPont de Nemours Inc. published this content on 18 December 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 December 2019 16:05:10 UTC
DuPont de Nemours, Inc. specializes in the manufacture and marketing of specialty chemicals. The group provides copolymers, polyethylene, chloroform, fluorine, hydrofluoric acid, copper, hydroxylamine, precious metals, alumina hydroxide, ammonia, benzene, polyester fibers, propylene, wood pulp, acids, alcohols, chlorite, aldehydes, ethylene oxide, etc.
Net sales are distributed geographically as follows: the United States (32.4%), Asia/Pacific (43%), Europe/Middle East/Africa (18.3%), Latin America (4%) and Canada (2.3%).